News & Perspective

Oct 14, 2011

Oct 14, 2011

NIH contracts target broad-spectrum therapies for bioterror threats

(CIDRAP News) – The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.

Sep 09, 2008

Sep 09, 2008

HHS funds work on new anthrax antitoxin

(CIDRAP News) – Emergent BioSolutions Inc. recently announced that it won a federal contract worth $24.3 million to develop a monoclonal antibody treatment to block the effects of anthrax toxin.

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

Mar 06, 2007

Mar 06, 2007

Analysis of 1918 pandemic cites enduring mysteries

(CIDRAP News) – A new analysis of research into the 1918 influenza pandemic, undertaken to determine whether historical accounts can illuminate planning for possible future pandemics, reveals a surprising number of enduring mysteries.

Aug 19, 2005

Aug 19, 2005

Research sheds light on plague agent and potential vaccine

(CIDRAP News) – Two research reports on plague were recently released, one describing the mechanism that the plague bacterium uses to evade the body's immune system and the other describing a potential vaccine that was tested successfully in mice.

May 10, 2005

May 10, 2005

NIAID awards first Project Bioshield grants

Editor's note: This story was revised shortly after publication to reflect corrections issued by the National Institute of Allergy and Infectious Diseases on May 10. The corrections pertain to the total monetary amount of the grants and to the project descriptions for XOMA (US) LLC and DVC Dynport LLC.

Sep 30, 2003

Sep 30, 2003

NIAID report claims great progress in biodefense research

(CIDRAP News) – Federal health officials yesterday released a 37-page report that they say demonstrates "tremendous progress" in developing countermeasures for bioterrorism through federally funded research since early 2002.

Sep 05, 2003

Sep 05, 2003

HHS funds regional biodefense research centers

(CIDRAP News) – The US Department of Health and Human Services yesterday announced $350 million in grants for eight regional centers to lead and coordinate research on defenses against bioterrorism and emerging infectious diseases.

Mar 18, 2002

Mar 18, 2002

NIAID releases lengthy bioterrorism research agenda

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has released a 68-page report on its plan for expanding research on "Category A" bioterrorism agents: anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers, and botulism.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»